WTIC: Get Ready To Trade The Departure From $50.00 Per Barrel
Apr 21, 2017
Jeremy Parkinson
Finance
Written by Corey Rosenbloom Crude oil (StockCharts:$WTIC) has plunged toward the $50.00 per barrel level, collapsing from negative divergences into resistance. This was our forecast play for Oil – a bearish swing “down away from” the $54.00 level for members. Let’s see how it developed, study the pattern, and plan the next swing: Here’s a quote from […]
French Elections Preview And Gold
Apr 21, 2017
Jeremy Parkinson
Finance
The first round of presidential elections in France is held on Sunday. What can we expect from that event and how can it affect the gold market? In the recent edition of the Market Overview, we wrote that centrist Emmanuel Macron and nationalistic Marine Le Pen were expected to move on the next round. However, the […]
E
Market Briefing For Friday, April 21
Apr 21, 2017
Jeremy Parkinson
Finance
The ‘cat leaped like a tiger’ over the 50-Day Moving Average, and held it with a lot of help from a stronger Dollar, firmer Oil despite ongoing Contango in Brent and certainly the ongoing policies to improve forward US growth. There are many issues; political, fundamental, technical and even statistical, that pervade presently. Not to […]
Waiting For A Direction – Friday, April 21
Apr 21, 2017
Jeremy Parkinson
Finance
Over the past week, my core market health indicators bounced around, but had no significant changes. With most of the indicators compressing near the zero line, it appears that the market is waiting for a direction. One thing of note, is that my measures of market quality are very close to going negative. I suspect […]
Our State-Corporate Plantation Economy
Apr 21, 2017
Jeremy Parkinson
Finance
We’ve been persuaded that the state-cartel Plantation Economy is “capitalist,” but it isn’t. It’s a rentier skimming machine. I have often discussed the manner in which the U.S. economy is a Plantation Economy, meaning it has a built-in financial hierarchy with corporations at the top dominating a vast populace of debt-serfs/ wage slaves with little […]
Brick & Mortar Retail Struggles Attributable To Growth In E-Commerce
Apr 21, 2017
Jeremy Parkinson
Finance
Today another retailer announced it will be closing up shop, Bebe Stores, Inc. (BEBE), making it the 15th retailer to go under this year. By the end of May BEBE plans to liquidate its approximately 180 stores. This nearly matches the 18 retail bankruptcies for all of 2016. Source: S&P Global: Market Intelligence With the consumer accounting […]
Jimmy Carter And The Energy Crisis That Never Happened
Apr 21, 2017
Jeremy Parkinson
Finance
Forty years ago tonight, President Jimmy Carter delivered his Address to the Nation on National Energy Policy, better known as the “Moral Equivalent of War” speech. Seated behind his ornate desk in the Oval Office and wearing a sober pinstriped suit, he offered a litany of dark predictions: “The oil and natural gas we rely on for […]
With Harrison Having Switched Trains, Analysts Upgrade CSX, Cut CP
Apr 21, 2017
Jeremy Parkinson
Finance
Two railways names linked by a recent executive change – CSX (CSX) and Canadian Pacific (CP) – are on track for weekly advances after each reported quarterly results earlier this week. However, CSX and Canadian Pacific’s reports have sparked different reactions on Wall Street, with analysts upgrading the former to Buy-equivalent ratings and a firm […]
3 Strong Buy Balanced Mutual Funds To Consider
Apr 21, 2017
Jeremy Parkinson
Finance
Balanced funds provide investors with the convenience of buying into a single fund rather than holding both equity and bond funds. This category of funds also reduces a portfolio’s volatility, while providing higher returns than pure fixed income investments. The fund managers also enjoy the flexibility of varying the proportion of equity and fixed income […]
Onconova Therapeutics Announces Pricing Of Public Offering Of Common Stock
Apr 21, 2017
Jeremy Parkinson
Finance
NEWTOWN, Pa., April 21, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (Nasdaq: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS) today announced that it has priced an underwritten public offering of 2,476,190 shares of its common stock, at a […]